{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T15:42:51Z","timestamp":1785598971817,"version":"3.56.0"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2021YFC2103402"],"award-info":[{"award-number":["2021YFC2103402"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography A"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.chroma.2025.466577","type":"journal-article","created":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T07:48:37Z","timestamp":1764229717000},"page":"466577","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["A stable all-D peptide ligand inspires broad-spectrum affinity and high performance in the purification of COVID-19 vaccines"],"prefix":"10.1016","volume":"1766","author":[{"given":"Jing","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8263-7595","authenticated-orcid":false,"given":"Linling","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0592-4192","authenticated-orcid":false,"given":"Qinghong","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.chroma.2025.466577_bib0001","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.81702","article-title":"Structure of SARS-CoV-2 M protein in lipid nanodiscs","volume":"11","author":"Dolan","year":"2022","journal-title":"Elife"},{"issue":"5","key":"10.1016\/j.chroma.2025.466577_bib0002","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.vaccine.2023.12.031","article-title":"How manufacturing won or lost the COVID-19 vaccine race","volume":"42","author":"King","year":"2024","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.chroma.2025.466577_bib0003","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.3390\/vaccines11061045","article-title":"A review of inactivated COVID-19 vaccine development in China: focusing on safety and efficacy in special populations","volume":"11","author":"Hu","year":"2023","journal-title":"Vaccines"},{"issue":"4","key":"10.1016\/j.chroma.2025.466577_bib0004","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1021\/acscentsci.1c00120","article-title":"A comprehensive review of the global efforts on COVID-19 vaccine development","volume":"7","author":"Li","year":"2021","journal-title":"ACS Cent. Sci."},{"issue":"1","key":"10.1016\/j.chroma.2025.466577_bib0005","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/s41392-022-00996-y","article-title":"COVID-19 vaccine development: milestones, lessons and prospects","volume":"7","author":"Li","year":"2022","journal-title":"Signal Transduct. Target Ther."},{"issue":"5","key":"10.1016\/j.chroma.2025.466577_bib0006","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.24418","article-title":"An overview on inactivated and live-attenuated SARS-CoV-2 vaccines","volume":"36","author":"Khoshnood","year":"2022","journal-title":"J. Clin. Lab. Anal."},{"issue":"7911","key":"10.1016\/j.chroma.2025.466577_bib0007","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/s41586-022-04690-5","article-title":"Defining the risk of SARS-CoV-2 variants on immune protection","volume":"605","author":"DeGrace","year":"2022","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.chroma.2025.466577_bib0008","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.cell.2020.07.012","article-title":"The impact of mutations in SARS-CoV-2 spike on viral infectivity and antigenicity","volume":"182","author":"Li","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.chroma.2025.466577_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2024.464851","article-title":"Affinity chromatography for virus-like particle manufacturing: challenges, solutions, and perspectives","volume":"1721","author":"Ma","year":"2024","journal-title":"J. Chromatogr. A"},{"issue":"8","key":"10.1016\/j.chroma.2025.466577_bib0010","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1002\/bit.28495","article-title":"Peptide ligands for the affinity purification of adeno-associated viruses from HEK 293 cell lysates","volume":"120","author":"Chu","year":"2023","journal-title":"Biotechnol. Bioeng."},{"issue":"9","key":"10.1016\/j.chroma.2025.466577_bib0011","doi-asserted-by":"crossref","first-page":"770","DOI":"10.3390\/membranes13090770","article-title":"Affinity and pseudo-affinity membrane chromatography for viral vector and vaccine purifications: a review","volume":"13","author":"Lothert","year":"2023","journal-title":"Membranes"},{"key":"10.1016\/j.chroma.2025.466577_bib0012","series-title":"Viral vectors for gene therapy: methods and protocols","first-page":"89","article-title":"Overview of current scalable methods for purification of viral vectors","author":"Segura","year":"2011"},{"issue":"11","key":"10.1016\/j.chroma.2025.466577_bib0013","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1038\/mt.2009.128","article-title":"A simplified baculovirus-AAV expression vector system coupled with one-step affinity purification yields high-titer rAAV stocks from insect cells","volume":"17","author":"Smith","year":"2009","journal-title":"Mol. Ther."},{"issue":"3","key":"10.1016\/j.chroma.2025.466577_bib0014","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1089\/hum.2013.184","article-title":"OneBac: platform for scalable and high-titer production of adeno-associated virus serotype 1-12 vectors for gene therapy","volume":"25","author":"Mietzsch","year":"2014","journal-title":"Hum. Gene. Ther."},{"key":"10.1016\/j.chroma.2025.466577_bib0015","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.omtm.2020.10.001","article-title":"Characterization of AAV-specific affinity ligands: consequences for vector purification and development strategies","volume":"19","author":"Mietzsch","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"issue":"7","key":"10.1016\/j.chroma.2025.466577_bib0016","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1128\/IAI.66.7.3279-3289.1998","article-title":"Human and murine immune responses to a novel Leishmania major recombinant protein encoded by members of a multicopy gene family","volume":"66","author":"Webb","year":"1998","journal-title":"Infect. Immun."},{"key":"10.1016\/j.chroma.2025.466577_bib0017","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2020.618615","article-title":"Design, expression, purification, and characterization of a YFP-tagged 2019-nCov spike receptor-binding domain construct","volume":"8","author":"Bierig","year":"2020","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"6","key":"10.1016\/j.chroma.2025.466577_bib0019","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1021\/acscentsci.0c01708","article-title":"Discovery of cyclic peptide ligands to the SARS-CoV-2 spike protein using mRNA display","volume":"7","author":"Norman","year":"2021","journal-title":"ACS Cent. Sci."},{"issue":"1","key":"10.1016\/j.chroma.2025.466577_bib0020","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1021\/acscentsci.0c01309","article-title":"Discovery of high-affinity peptide binders for the SARS-CoV-2 spike protein","volume":"7","author":"Pomplun","year":"2021","journal-title":"ACS Cent. Sci."},{"issue":"17","key":"10.1016\/j.chroma.2025.466577_bib0021","doi-asserted-by":"crossref","first-page":"6358","DOI":"10.3390\/molecules28176358","article-title":"Interface-based design of high-affinity affibody ligands for the purification of RBD from spike proteins","volume":"28","author":"Song","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.chroma.2025.466577_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2024.464912","article-title":"Identification of a broad-spectrum high-affinity peptide ligand for the purification of spike proteins","volume":"1723","author":"Hu","year":"2024","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.chroma.2025.466577_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2025.126951","article-title":"Enhanced sulfate pseudo-affinity chromatography using monolith-like particle architecture for purifying SARS-CoV-2","volume":"53","author":"Kadoi","year":"2025","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.chroma.2025.466577_bib0024","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.cell.2022.12.018","article-title":"Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants","volume":"186","author":"Wang","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.chroma.2025.466577_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2025.465685","article-title":"Broad-spectrum affinity chromatography of SARS-CoV-2 and Omicron vaccines from Ligand screening to purification","volume":"1743","author":"Ma","year":"2025","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.chroma.2025.466577_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.137059","article-title":"Discovery of broad-spectrum high-affinity peptide ligands of spike protein for the vaccine purification of SARS-CoV-2 and Omicron variants","volume":"283","author":"Ma","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"issue":"28","key":"10.1016\/j.chroma.2025.466577_bib0027","doi-asserted-by":"crossref","first-page":"8500","DOI":"10.1021\/la5017438","article-title":"Biomimetic design of affinity peptide ligand for capsomere of virus-like particle","volume":"30","author":"Li","year":"2014","journal-title":"Langmuir"},{"issue":"12","key":"10.1016\/j.chroma.2025.466577_bib0028","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1002\/biot.201600025","article-title":"Retroviral particles are effectively purified on an affinity matrix containing peptides selected by phage-display","volume":"11","author":"Fernandes","year":"2016","journal-title":"Biotechnol. J."},{"issue":"2","key":"10.1016\/j.chroma.2025.466577_bib0029","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1021\/acschembio.2c00735","article-title":"Discovery of all-D-peptide inhibitors of SARS-CoV-2 3C-like protease","volume":"18","author":"Eberle","year":"2023","journal-title":"ACS Chem. Biol."},{"issue":"6","key":"10.1016\/j.chroma.2025.466577_bib0030","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1021\/acssensors.2c00518","article-title":"D-amino acid-based antifouling peptides for the construction of electrochemical biosensors capable of assaying proteins in serum with enhanced stability","volume":"7","author":"Zhao","year":"2022","journal-title":"ACS Sens."},{"issue":"11","key":"10.1016\/j.chroma.2025.466577_bib0031","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1002\/cbic.201300228","article-title":"Improving binding affinity and stability of peptide ligands by substituting glycines with D-amino acids","volume":"14","author":"Chen","year":"2013","journal-title":"ChemBioChem"},{"issue":"7","key":"10.1016\/j.chroma.2025.466577_bib0032","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1021\/acssuschemeng.9b05889","article-title":"\u0391-aminoisobutyric acid-stabilized peptide sams with low nonspecific protein adsorption and resistance against marine biofouling","volume":"8","author":"Beyer","year":"2020","journal-title":"ACS Sustain. Chem. Eng."},{"issue":"24","key":"10.1016\/j.chroma.2025.466577_bib0033","doi-asserted-by":"crossref","first-page":"7099","DOI":"10.1021\/bi010036j","article-title":"Generality of peptide cyclization catalyzed by isolated thioesterase domains of nonribosomal peptide synthetases","volume":"40","author":"Kohli","year":"2001","journal-title":"Biochemistry"},{"issue":"2","key":"10.1016\/j.chroma.2025.466577_bib0034","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1021\/ja0666553","article-title":"Interplay among folding, sequence, and lipophilicity in the antibacterial and hemolytic activities of \u0391\/\u0392-peptides","volume":"129","author":"Schmitt","year":"2007","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.chroma.2025.466577_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104389","article-title":"New insight into enzymatic hydrolysis of peptides with site-specific amino acid D-isomerization","volume":"105","author":"Yan","year":"2020","journal-title":"Bioorg. Chem."},{"issue":"20","key":"10.1016\/j.chroma.2025.466577_bib0036","doi-asserted-by":"crossref","first-page":"14955","DOI":"10.1021\/acs.jmedchem.1c00655","article-title":"Computational design of potent D-peptide inhibitors of SARS-CoV-2","volume":"64","author":"Valiente","year":"2021","journal-title":"J. Med. Chem."},{"issue":"26","key":"10.1016\/j.chroma.2025.466577_bib0037","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2426554122","article-title":"De novo design of D-peptide ligands: application to Influenza virus hemagglutinin","volume":"122","author":"Juraszek","year":"2025","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1\u20132","key":"10.1016\/j.chroma.2025.466577_bib0038","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.drudis.2009.10.009","article-title":"Synthetic therapeutic peptides: science and market","volume":"15","author":"Vlieghe","year":"2010","journal-title":"Drug Discov. Today"},{"issue":"15","key":"10.1016\/j.chroma.2025.466577_bib0039","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1021\/acs.jcim.2c00500","article-title":"Targeting the receptor-binding motif of SARS-CoV-2 with D-peptides mimicking the ACE2 binding helix: lessons for inhibiting Omicron and future variants of concern","volume":"62","author":"Valiente","year":"2022","journal-title":"J. Chem. Inf. Model."},{"issue":"3","key":"10.1016\/j.chroma.2025.466577_bib0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0229206","article-title":"Assessing the binding properties of the anti-PD-1 antibody landscape using label-free biosensors","volume":"15","author":"Brown","year":"2020","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.chroma.2025.466577_bib0041","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"Software news and update Autodock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"issue":"7807","key":"10.1016\/j.chroma.2025.466577_bib0042","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41586-020-2180-5","article-title":"Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor","volume":"581","author":"Lan","year":"2020","journal-title":"Nature"},{"issue":"28","key":"10.1016\/j.chroma.2025.466577_bib0043","doi-asserted-by":"crossref","first-page":"8500","DOI":"10.1021\/la5017438","article-title":"Biomimetic design of affinity peptide ligand for capsomere of virus-like particle","volume":"30","author":"Li","year":"2014","journal-title":"Langmuir"},{"issue":"9","key":"10.1016\/j.chroma.2025.466577_bib0044","doi-asserted-by":"crossref","first-page":"4656","DOI":"10.1021\/acs.jcim.1c00783","article-title":"Computationally designed ACE2 decoy receptor binds SARS CoV-2 spike (S) protein with tight nanomolar affinity","volume":"61","author":"Havranek","year":"2021","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.chroma.2025.466577_bib0045","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3389\/fmolb.2017.00087","article-title":"Recent developments and applications of the Mmpbsa method","volume":"4","author":"Wang","year":"2018","journal-title":"Front. Mol. Biosci."},{"issue":"1","key":"10.1016\/j.chroma.2025.466577_bib0046","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/pro.3781","article-title":"Shortcuts for faster image creation in Pymol","volume":"29","author":"Mooers","year":"2020","journal-title":"Protein Sci."},{"key":"10.1016\/j.chroma.2025.466577_bib0047","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2021.462070","article-title":"Two dimensional anion exchange-size exclusion chromatography combined with mathematical modeling for downstream processing of foot and mouth disease vaccine","volume":"1643","author":"Hossienizadeh","year":"2021","journal-title":"J. Chromatogr. A"},{"issue":"18","key":"10.1016\/j.chroma.2025.466577_bib0048","doi-asserted-by":"crossref","first-page":"10273","DOI":"10.1002\/anie.202100345","article-title":"Neutralizing aptamers block S\/rbd-Ace2 interactions and prevent host cell infection","volume":"60","author":"Liu","year":"2021","journal-title":"Angew. Chem. Int. Ed."},{"issue":"2","key":"10.1016\/j.chroma.2025.466577_bib0049","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1007\/s11684-021-0906-x","article-title":"Sars-Cov-2 variants, Immune escape, and countermeasures","volume":"16","author":"Zhang","year":"2022","journal-title":"Front. Med."},{"issue":"5","key":"10.1016\/j.chroma.2025.466577_bib0050","doi-asserted-by":"crossref","first-page":"e2381","DOI":"10.1002\/rmv.2381","article-title":"Evolution of the SARS-CoV-2 Omicron variants BA.1 to BA.5: implications for immune escape and transmission","volume":"32","author":"Shrestha","year":"2022","journal-title":"Rev. Med. Virol."},{"issue":"7","key":"10.1016\/j.chroma.2025.466577_bib0051","doi-asserted-by":"crossref","first-page":"13384","DOI":"10.3390\/molecules200713384","article-title":"Molecular docking and structure-based drug design strategies","volume":"20","author":"Ferreira","year":"2015","journal-title":"Molecules"},{"issue":"7","key":"10.1016\/j.chroma.2025.466577_bib0052","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.3390\/molecules27072105","article-title":"Molecular dynamics Simulations: advances and applications","volume":"27","author":"Filipe","year":"2022","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.chroma.2025.466577_bib0053","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e12890","article-title":"Bionics design of affinity peptide inhibitors for SARS-CoV-2 RBD to block SARS-CoV-2 RBD-ACE2 interactions","volume":"9","author":"Liu","year":"2023","journal-title":"Heliyon"},{"issue":"6","key":"10.1016\/j.chroma.2025.466577_bib0054","first-page":"2221","article-title":"Consensus docking and MM-PBSA computations identify putative furin protease inhibitors for developing potential therapeutics against COVID-19, Struct","volume":"33","author":"Dankwa","year":"2022","journal-title":"Chem"},{"issue":"3","key":"10.1016\/j.chroma.2025.466577_bib0055","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1021\/acschemneuro.8b00440","article-title":"d-enantiomeric rthlvffark-NH2: a potent multifunctional decapeptide inhibiting Cu2+-mediated amyloid \u03b2-protein aggregation and remodeling Cu2+-mediated amyloid \u03b2 aggregates","volume":"10","author":"Liu","year":"2019","journal-title":"ACS Chem. Neurosci."},{"issue":"7","key":"10.1016\/j.chroma.2025.466577_bib0056","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1021\/acs.langmuir.9b03832","article-title":"Biomimetic design of peptide neutralizer of Ebola virus with molecular simulation","volume":"36","author":"Hou","year":"2020","journal-title":"Langmuir"},{"issue":"5","key":"10.1016\/j.chroma.2025.466577_bib0057","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.apsb.2018.06.006","article-title":"Efficacy of inverso isomer of cendr peptide on tumor tissue penetration","volume":"8","author":"Wang","year":"2018","journal-title":"Acta. Pharm. Sin. B"},{"issue":"3","key":"10.1016\/j.chroma.2025.466577_bib0058","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/j.1398-9995.1991.tb00576.x","article-title":"Bovine serum albumin immunization: a new risk of allergy during protocols for in vitro fertilization","volume":"46","author":"Moneret-Vautrin","year":"1991","journal-title":"Allergy"},{"key":"10.1016\/j.chroma.2025.466577_bib0059","doi-asserted-by":"crossref","DOI":"10.1016\/j.seppur.2023.123588","article-title":"Protein adsorption to diethylaminoethyl-dextran grafted macroporous cellulose microspheres: a critical pore size for enhanced adsorption capacity and uptake kinetic","volume":"314","author":"Qiao","year":"2023","journal-title":"Sep. Purif. Technol."},{"issue":"1","key":"10.1016\/j.chroma.2025.466577_bib0060","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3390\/vaccines12010056","article-title":"Evaluation of the robustness verification of downstream production process for inactivated SARS-CoV-2 vaccine and different chromatography medium purification effects","volume":"12","author":"Pang","year":"2024","journal-title":"Vaccines"},{"issue":"2","key":"10.1016\/j.chroma.2025.466577_bib0061","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3390\/vaccines12020138","article-title":"Enhanced downstream processing for a cell-based Avian influenza (H5N1) vaccine","volume":"12","author":"Li","year":"2024","journal-title":"Vaccines"},{"issue":"6","key":"10.1016\/j.chroma.2025.466577_bib0062","doi-asserted-by":"crossref","first-page":"949","DOI":"10.3390\/vaccines10060949","article-title":"Methodology of purification of inactivated cell-culture-grown SARS-CoV-2 using size-exclusion chromatography","volume":"10","author":"Kovpak","year":"2022","journal-title":"Vaccines"},{"key":"10.1016\/j.chroma.2025.466577_bib0063","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2023.464337","article-title":"The downstream bioprocess toolbox for therapeutic viral vectors","volume":"1709","author":"Kilgore","year":"2023","journal-title":"J. Chromatogr. A"},{"issue":"1","key":"10.1016\/j.chroma.2025.466577_bib0064","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.virol.2011.05.014","article-title":"Immunogenicity of low-pH treated whole viral influenza vaccine","volume":"417","author":"Quan","year":"2011","journal-title":"Virology"},{"issue":"8","key":"10.1016\/j.chroma.2025.466577_bib0065","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"A novel coronavirus from patients with pneumonia in China, 2019","volume":"382","author":"Zhu","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.chroma.2025.466577_bib0066","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2022.463701","article-title":"Development of peptide affinity ligands for the purification of polyclonal and monoclonal Fabs from recombinant fluids","volume":"1687","author":"Kilgore","year":"2023","journal-title":"J. Chromatogr. A"}],"container-title":["Journal of Chromatography A"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021967325009215?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021967325009215?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T13:22:55Z","timestamp":1768483375000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021967325009215"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":65,"alternative-id":["S0021967325009215"],"URL":"https:\/\/doi.org\/10.1016\/j.chroma.2025.466577","relation":{},"ISSN":["0021-9673"],"issn-type":[{"value":"0021-9673","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A stable all-D peptide ligand inspires broad-spectrum affinity and high performance in the purification of COVID-19 vaccines","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography A","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chroma.2025.466577","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"466577"}}